Here, we revisit available clinical and preclinical evidence on the role(s) of PTX3 in AMD and DR, with major regard to current hypotheses on the involvement of this pentraxin in their pathogenesis, and its potential as a diagnostic/prognostic biomarker (see Table 1). Here, PTX3 is linked to age-related macular degeneration.